Search Results - "Starrenburg, Ingrid C. W."

Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab by von dem Borne, PA, Beaumont, F, Starrenburg, CW, Oudshoorn, M, Hale, G, Falkenburg, JH, Fibbe, WE, Willemze, R, Barge, RM

“…Dept. of Hematology, Leiden University Medical Center, Leiden, The Netherlands. P.A.von_dem_Borne@lumc.nl HLA-matched unrelated donor (MUD) stem cell…”
Get full text

Expression of co‐stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis by Brouwer, Rolf E., Hoefnagel, Juliette, Van Der Burg, Boudewijn Borger, Jedema, Inge, Zwinderman, Koos H., Starrenburg, Ingrid C. W., Kluin‐Nelemans, Hanneke C., Barge, Renee M. Y., Willemze, Roel, Falkenburg, J. H. Frederik

“…The expression of adhesion and co‐stimulatory molecules, and chemokine and death receptors such as tumour necrosis factor (TNF) and FAS on acute myeloid…”
Get full text

Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft (‘Campath in the bag’) by von dem Borne, Peter A, Ingrid Starrenburg, CWJ, Halkes, Stijn JM, Erik Marijt, WA, Fibbe, Willem E, Frederik Falkenburg, JH, Willemze, Roel

“…Reduced-intensity conditioning (RIC) has allowed the use of allogeneic stem cell transplantation (alloSCT) for haematological malignancies in elderly patients…”
Get full text

Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors by Barge, Renée M Y, Osanto, Susanne, Marijt, W A F Erik, Starrenburg, C W J Ingrid, Fibbe, Willem E, Nortier, J W R Hans, Falkenburg, J H Frederik, Willemze, Roel

“…Allogeneic stem cell transplantation (alloSCT) following reduced-intensity conditioning offers a relatively nontoxic regimen while preserving rapid and…”
Get full text

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease by Posthuma, Eduardus F.M, Marijt, Erik W.A.F, Barge, Renee M.Y, van Soest, Ronald A, Baas, Inge O, Starrenburg, C.W.J.Ingrid, van Zelderen-Bhola, Shama L, Fibbe, Willem E, Smit, Wim M, Willemze, Roel, Falkenburg, J.H.Frederik

“…Donor lymphocyte infusion (DLI) results in complete cytogenetic remission (CCR) of relapsed chronic-phase chronic myeloid leukemia (CML-CP) after allogeneic…”
Get full text